|
Issue |
Title |
|
Vol 2013, No 5 (2013) |
Concert Pharmaceuticals Snags Celgene as a Partner for its DCE Platform® |
Abstract
|
Heather Cartwright |
|
Vol 2006, No 77 (2006) |
Conference Report: Drug Discovery Partnerships and Outsourcing |
Abstract
pdf
|
Business Review Editor |
|
Vol 2012, No 6 (2012) |
Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry |
Abstract
|
Cynthia Tso, Jansen Jacob |
|
Vol 2012, No 2 (2012) |
Constellation and Genentech Form Broad Epigenetics Collaboration with Buyout Option |
Abstract
|
Heather Cartwright |
|
Vol 2006, No 76 (2006) |
Controlling Value in Deals |
Abstract
html
|
Fintan Walton |
|
Vol 2009, No 10 (2009) |
Cool Hats |
Abstract
jpg
|
Clive Goddard |
|
Vol 2003, No 42 (2003) |
Corgentech Clinches Bristol-Myers Squibb Alliance |
Abstract
pdf
|
Business Review Editor |
|
Vol 2005, No 56 (2005) |
Corixa Hands Over Bexxar® Rights to GSK |
Abstract
|
Business Review Editor |
|
Vol 2013, No 9 (2013) |
Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi |
Abstract
|
Heather Cartwright |
|
Vol 2009, No 5 (2009) |
Cornerstone's Strategic Transaction with Chiesi |
Abstract
|
Taskin Ahmed |
|
Vol 2022, No 8 (2022) |
Could Biopharma M&A Activity be on the Rise? |
Abstract
pdf
html
|
Lucy Haggerty & Taskin Ahmed |
|
Vol 2009, No 3 (2009) |
Could J&J Trip up the Merck and Schering-Plough Deal? |
Abstract
|
Taskin Ahmed |
|
Vol 2005, No 64 (2005) |
Covance Acquires Clinical Services Facility from West Pharmaceutical |
Abstract
pdf
|
Business Review Editor |
|
Vol 2010, No 9 (2010) |
Covance Becomes Sanofi-aventis’ R&D Partner |
Abstract
|
Heather Cartwright |
|
Vol 2009, No 5 (2009) |
Covidien Acquires VNUS Medical Technologies for US$440 M |
Abstract
|
Taskin Ahmed |
|
Vol 2020, No 12 (2020) |
Covis Group Acquires AMAG Pharmaceuticals for US$498 M |
Abstract
pdf
html
|
Sasha Yachu & Michelle Liu |
|
Vol 2006, No 67 (2006) |
Crucell and Berna Biotech to Create Large Independent Vaccine Company |
Abstract
pdf
|
Business Review Editor |
|
Vol 2002, No 28 (2002) |
Crucell and NatImmune Sign Licensing Agreement |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 74 (2006) |
CrystaX Pharmaceuticals SL |
Abstract
|
Business Review Editor |
|
Vol 2020, No 7 (2020) |
CSL Behring Licenses Phase III Haemophilia B Gene Therapy Candidate from uniQure |
Abstract
pdf
html
|
Sasha Yachu & Michelle Liu |
|
Vol 2004, No 44 (2004) |
CSL Combines with Aventis to Create ZLB Behring |
Abstract
pdf
|
Business Review Editor |
|
Vol 2021, No 12 (2021) |
CSL Hands Over US$11.7 B to Acquire Vifor Pharma |
Abstract
pdf
html
|
Sasha Yachu |
|
Vol 2008, No 99 (2008) |
CSL Seeks to Solidfy its Position by Acquiring Talecris |
Abstract
pdf
html
|
Taskin Ahmed |
|
Vol 2013, No 3 (2013) |
Cubist Gains Option to Acquire Adynxx with Diversification in Mind |
Abstract
|
Heather Cartwright |
|
Vol 2011, No 11 (2011) |
Cubist Looks to Opioid Receptor Antagonists with Potential US$415 M Adolor Takeover |
Abstract
|
Heather Cartwright |
|
Vol 2004, No 50 (2004) |
CuraGen Licenses Seattle Genetics’ ADC Technology |
Abstract
pdf
|
Business Review Editor |
|
Vol 2004, No 49 (2004) |
CuraGen Licenses TopoTarget’s HDAC Inhibitor |
Abstract
pdf
|
Business Review Editor |
|
Vol 2005, No 59 (2005) |
Curis and Genentech Join Forces Again |
Abstract
pdf
|
Business Review Editor |
|
Vol 2022, No 2 (2022) |
Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform |
Abstract
pdf
html
|
Ayush Saxena & Lucy Haggerty |
|
Vol 2008, No 100 (2008) |
CV Therapeutics Aims High Through its Agreement with Menarini |
Abstract
pdf
html
|
Sally Mardikian PhD |
|
Vol 2018, No 7 (2018) |
CVC Capital Acquires Controlling Stake in Recordati |
Abstract
pdf
html
|
Jasmine Kalsi |
|
Vol 2005, No 64 (2005) |
Cyto Pulse Collaborates with US Army |
Abstract
pdf
|
Business Review Editor |
|
Vol 2007, No 80 (2007) |
Cytokinetics and Amgen Enter into Collaboration for Heart Failure |
Abstract
pdf
|
Business Review Editor |
|
Vol 2013, No 7 (2013) |
Cytokinetics Gains Astellas as Partner in Field of Skeletal Muscle Activation |
Abstract
|
Heather Cartwright |
|
Vol 2008, No 99 (2008) |
Cytos Signs Vaccines Deal with Pfizer |
Abstract
pdf
html
|
Taskin Ahmed |
|
Vol 2007, No 82 (2007) |
Cytyc - A Positive Outlook |
Abstract
pdf
|
Business Review Editor |
|
Vol 2005, No 61 (2005) |
Dacogen (decitabine) |
Abstract
pdf
|
Business Review Editor |
|
Vol 2012, No 3 (2012) |
Daiichi Sankyo and GSK to Establish Vaccines Joint Venture in Japan |
Abstract
|
Heather Cartwright |
|
Vol 2008, No 96 (2008) |
Daiichi Sankyo Boosts Oncology Portfolio with Acquisition of Biotech, U3 Pharma |
Abstract
pdf
html
|
Helen Scrutton |
|
Vol 2008, No 97 (2008) |
Daiichi Sankyo Diversifies into Generics through Major Investment in Indian Giant |
Abstract
pdf
html
|
Sally Mardikian PhD |
|
Vol 2011, No 3 (2011) |
Daiichi Sankyo Targets US Oncology Market with US$935 M Plexxikon Acquisition |
Abstract
|
Heather Cartwright |
|
Vol 2005, No 55 (2005) |
Dainippon and Sumitomo Follow in the Footsteps of Yamanouchi and Fujisawa |
Abstract
pdf
|
Business Review Editor |
|
Vol 2013, No 4 (2013) |
Dainippon Sumitomo Licenses Japanese Rights to Two Redox-Directed Drugs from Edison Pharmaceuticals |
Abstract
|
Heather Cartwright |
|
Vol 2012, No 3 (2012) |
Dainippon Sumitomo Pharma Expands its Oncology Presence with Boston Biomedical Acquisition |
Abstract
|
Heather Cartwright |
|
Vol 2021, No 7 (2021) |
Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition |
Abstract
pdf
html
|
Debadrita Paul |
|
Vol 2005, No 58 (2005) |
De Novo Pharmaceuticals Ltd |
Abstract
|
Business Review Editor |
|
Vol 2007, No 83 (2007) |
Deal box |
Details
jpg
|
Business Review Editor |
|
Vol 2005, No 56 (2005) |
Deal Making in the Biopharmaceutical Sector |
Abstract
pdf
|
Business Review Editor |
|
Vol 2002, No 31 (2002) |
Deal Making in the Drug Delivery Sector |
Abstract
|
Business Review Editor |
|
Vol 2006, No 68 (2006) |
Deal Making in the New Healthcare Landscape |
Abstract
pdf
|
Business Review Editor |
|
Vol 2002, No 25 (2002) |
Deal Making in the Pharmaceutical Fine Chemical Industry |
Abstract
|
Business Review Editor |
|
Vol 2006, No 74 (2006) |
Deal Making Review: 2000-2005, with Projections for 2006 |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 72 (2006) |
Deal Making Spotlights on Big Pharma |
Abstract
pdf
|
Business Review Editor |
|
Vol 2009, No 9 (2009) |
Deal Making Trends in Oncology |
Abstract
|
Josef Walker |
|
Vol 2005, No 59 (2005) |
Deal Making Trends of Top Pharma Companies |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 73 (2006) |
Deal termination |
Details
jpg
|
Business Review Editor |
|
Vol 2019, No 12 (2019) |
Deal Trends in Gene Therapy |
Abstract
pdf
|
Michelle Liu & Taskin Ahmed |
|
Vol 2019, No 1 (2019) |
Deal Trends in Immuno-Oncology |
Abstract
pdf
|
Natasha Piper, Heather Cartwright & Taskin Ahmed |
|
Vol 2006, No 69 (2006) |
Dealing with Litigation |
Abstract
|
Business Review Editor |
|
Vol 2010, No 1 (2010) |
Dealing with the Wolf |
Abstract
jpg
|
Clive Goddard |
|
Vol 2012, No 1 (2012) |
Decision Maker |
Abstract
jpg
|
Clive Goddard |
|
Vol 2018, No 12 (2018) |
Decline in Big Pharma Deal Activity Mirrors Industry-wide Slowdown in Dealmaking |
Abstract
pdf
|
Jawala Prasad & Jasmine Kalsi |
|
Vol 2002, No 25 (2002) |
Degussa AG divests pharmaceutical interests |
Abstract
pdf
|
Business Review Editor |
|
Vol 2007, No 88 (2007) |
Delivering Success from Seed Capital Investment |
Abstract
pdf
|
Business Review Editor |
|
Vol 2004, No 51 (2004) |
Deltanoid’s and Abbott’s Renal Partnership |
Abstract
|
Business Review Editor |
|
Vol 2018, No 6 (2018) |
Denali Therapeutics Exercises Option to Acquire F-Star Gamma |
Abstract
pdf
html
|
Natasha Piper |
|
Vol 2002, No 28 (2002) |
Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform |
Abstract
pdf
|
Business Review Editor |
|
Vol 2003, No 34 (2003) |
Dendreon to Acquire Corvas |
Abstract
pdf
|
Business Review Editor |
|
Vol 2003, No 37 (2003) |
deVGen NV |
Abstract
pdf
|
Business Review Editor |
|
Vol 2002, No 28 (2002) |
Diacrin Licenses Transplantation Technology to Terumo |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 69 (2006) |
Diagnose This |
Abstract
html
|
Fintan Walton |
|
Vol 2006, No 74 (2006) |
Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 72 (2006) |
Diquafosol |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 69 (2006) |
Divestments and Acquisitions: A Changing Landscape |
Abstract
pdf
|
Business Review Editor |
|
Vol 2005, No 60 (2005) |
Dividing Opinion: Shire's Move to Purchase TKT |
Abstract
pdf
|
Business Review Editor |
|
Vol 2005, No 61 (2005) |
Don't Make Your Drug Deals Poison Pills |
Details
html
|
Fintan Walton |
|
Vol 2007, No 86 (2007) |
Dong Wha Goes Global with P&G |
Abstract
pdf
|
Business Review Editor |
|
Vol 2008, No 94 (2008) |
Dr. Reddy's Acquisition Sweeps through Europe |
Abstract
pdf
html
|
Sally Mardikian PhD |
|
Vol 2006, No 69 (2006) |
Dr. Reddy’s Acquires betapharm to Expand European Operations |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 76 (2006) |
Drastic Measures: Ligand Sells All its Marketed Products |
Abstract
pdf
|
Business Review Editor |
|
Vol 2003, No 33 (2003) |
Drug Delivery Alliance Development Process |
Abstract
|
Business Review Editor |
|
Vol 2002, No 24 (2002) |
Drug Royalty Companies |
Abstract
|
Business Review Editor |
|
Vol 2007, No 79 (2007) |
Drug Withdrawals: Pfizer the Latest Victim |
Abstract
|
Business Review Editor |
|
Vol 2002, No 28 (2002) |
DSM to Acquire Roche’s Vitamins and Fine Chemicals Division |
Abstract
pdf
|
Business Review Editor |
|
Vol 2006, No 74 (2006) |
Due Diligence |
Details
jpg
|
Business Review Editor |
|
Vol 2013, No 1 (2013) |
Dutch Start-Up Dezima Pharma In-Licenses First Pipeline Drug from Mitsubishi Tanabe |
Abstract
|
Heather Cartwright |
|
Vol 2009, No 8 (2009) |
DxS and AstraZeneca Collaborate on Iressa® Diagnostic |
Abstract
|
Taskin Ahmed |
|
Vol 2009, No 2 (2009) |
Dyax and Biogen Idec Expand Drug Discovery Deal |
Abstract
html
|
Taskin Ahmed |
|
Vol 2008, No 94 (2008) |
Dyax and Cubist Sign Deal for DX-88 Surgical Indications |
Abstract
pdf
html
|
Helen Scrutton |
|
Vol 2007, No 90 (2007) |
Dynavax Licenses HBV Vaccine to Merck & Co. |
Abstract
pdf
|
Business Review Editor |
|
Vol 2008, No 103 (2008) |
Dynavax’s Deal Termination with Merck is followed by a New Agreement with GSK |
Abstract
pdf
html
|
Sally Mardikian PhD |
|
Vol 2020, No 5 (2020) |
Dyno Therapeutics Launches with US$2 B Deals with Novartis and Sarepta |
Abstract
pdf
html
|
Michelle Liu |
|
Vol 2020, No 10 (2020) |
Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche |
Abstract
pdf
html
|
Pratika Pahwa & Michelle Liu |
|
Vol 2023, No 1 (2023) |
Early Signs of M&A Activity Heating Up in 2023 |
Abstract
pdf
html
|
Lucy Haggerty |
|
Vol 2006, No 77 (2006) |
Eastern Promise |
Abstract
html
|
Fintan Walton |
|
Vol 2008, No 92 (2008) |
Ebay |
Details
jpg
|
Business Review Editor |
|
Vol 2014, No 2 (2014) |
Edison and Dainippon Sumitomo Broaden Relationship with Discovery Alliance Targeting Redox Biochemistry |
Abstract
|
Heather Cartwright |
|
Vol 2008, No 94 (2008) |
Effective Benchmarking |
Abstract
|
Business Review Editor |
|
Vol 2014, No 3 (2014) |
Eisai and Biogen Idec Partner to Advance Alzheimer’s Disease Drug Candidates |
Abstract
|
Heather Cartwright |
|
Vol 2016, No 2 (2016) |
Eisai Bolsters Oncology Pipeline by Acquiring Rights to Huya’s Cancer Drug |
Abstract
pdf
html
|
Jasmine Kalsi & Taskin Ahmed |
|
901 - 1000 of 2581 Items |
<< < 5 6 7 8 9 10 11 12 13 14 > >> |